Case File №
#VI-2026-0894
Henan Sahe Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 11 | 7.2 | 5.3 | 10.0 | 30 Sep 2025 |
| Tirzepatide | D Poor | 7 | 7.3 | 3.4 | 10.0 | 3 Oct 2025 |
| Abaloparatide | X N/A | 1 | 8.4 | 8.4 | 8.4 | 13 Feb 2025 |
| ACE-031 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 |
| AICAR | X N/A | 1 | 7.1 | 7.1 | 7.1 | 8 Jul 2025 |
| Anadrol Oil | X N/A | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 2 Apr 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 8 Jul 2025 |
| Botulinum toxin | X N/A | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 7.0 | 7.0 | 7.0 | 8 Jul 2025 |
| Cabergoline | X N/A | 1 | 7.7 | 7.7 | 7.7 | 25 Apr 2025 |
| Cardiogen | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 |
| Cartalax | X N/A | 1 | 4.0 | 3.8 | 3.8 | 20 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 6.3 | 6.3 | 6.3 | 21 May 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 |
| Dermorphin | X N/A | 1 | 5.3 | 5.3 | 5.3 | 27 Feb 2025 |
| Dianabol | X N/A | 1 | 5.6 | 5.6 | 5.6 | 11 Jun 2025 |
| EPO | X N/A | 1 | 8.8 | 8.8 | 8.8 | 6 May 2025 |
| GW-501516 (Cardarine) | X N/A | 1 | 8.2 | 8.2 | 8.2 | 21 May 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| Ivermectin | X N/A | 1 | 7.5 | 7.5 | 7.5 | 8 Jul 2025 |
| L-Carnitine 500mg | X N/A | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 |
| Lipo-C 120mg | X N/A | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 |
| MT-1 | X N/A | 1 | 7.0 | 7.0 | 7.0 | 3 Jun 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 8.9 | 8.9 | 8.9 | 3 Jun 2025 |
| NandroMix 300 | X N/A | 1 | 5.3 | 5.3 | 5.3 | 3 Jul 2025 |
| Ovagen | X N/A | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 |
| PEG MGF | X N/A | 1 | 9.4 | 9.4 | 9.4 | 24 Apr 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 9.9 | 9.9 | 9.9 | 20 Jun 2025 |
| Prednisone | X N/A | 1 | 7.2 | 7.2 | 7.2 | 2 Apr 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 6.0 | 6.0 | 6.0 | 17 Dec 2024 |
| PTD-DBM | X N/A | 1 | 8.8 | 8.8 | 8.8 | 14 Jan 2025 |
| Semax | X N/A | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 8 Jul 2025 |
| Supertest 450 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 7 May 2025 |
| TB-500 FRAG | X N/A | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 |
| Test Enanthate | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Jul 2025 |
| Testagen | X N/A | 1 | 9.4 | 9.4 | 9.4 | 2 Apr 2025 |
| Tirzepatide 30mg Pen Kit | X N/A | 1 | 8.7 | 8.7 | 8.7 | 17 Dec 2024 |
| Vitamin D3 20000iu/ml | X N/A | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| Winstrol Oil (Stanozolol) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 |
Exhibit II
Evidence Log
46 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 6.8 A | 1g | 1.0g | -0.9% | 96.23% | 8f5bsp | Lab F | Public |
| 25 May 2026 | Ivermectin | 7.7 A | 10mg | 9.9mg | -1.2% | 99.72% | qwe92q | Lab G | Community |
| 24 May 2026 | AICAR | 6.7 A | 20mg | 24.1mg | +20.3% | 97.61% | y300i7 | Lab B | Community |
| 24 May 2026 | Cardiogen | 7.6 A | 20mg | 22.3mg | +11.3% | 97.18% | ylwev3 | Lab G | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.7 A | 5mg | 5.7mg | +14.2% | 95.67% | dj6wli | Lab C | Community |
| 24 May 2026 | HGH 191AA (Somatropin) | 8.2 A | 30mg | 28.7mg | -4.4% | 97.87% | j7804l | Lab F | Public |
| 24 May 2026 | Cabergoline | 4.4 C | 100mg | 94.5mg | -5.5% | 98.11% | q48bid | Lab E | Public |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 10.0 A | 2mg | 2.5mg | +24.8% | 95.60% | 9lrmou | Lab C | Community |
| 23 May 2026 | Retatrutide | 8.0 A | 30mg | 29.1mg | -3.0% | 99.90% | (no batch ID) | Lab E | Public |
| 23 May 2026 | Abaloparatide | 9.5 A | 5mg | 5.5mg | +9.6% | 97.91% | 51b5ij | Lab E | Public |
| 23 May 2026 | Testagen | 10.0 A | 50mg | 56.1mg | +12.1% | 99.68% | 95g5xm | Lab C | Community |
| 23 May 2026 | Vitamin D3 20000iu/ml | 8.9 A | 100mg/ml | 105.9mg/ml | +5.9% | 99.42% | bd7fve | Lab A | Community |
| 21 May 2026 | Retatrutide | 6.7 B | 10mg | 10.7mg | +7.0% | 98.38% | RT30/2025-1010 | Lab E | Public |
| 21 May 2026 | EPO | 10.0 A | 50mg | 48.4mg | -3.2% | 99.82% | sm1qqj | Lab D | Community |
| 21 May 2026 | NandroMix 300 | 7.4 A | 200mg/ml | 200.7mg/ml | +0.3% | 99.17% | z6q9mo | Lab B | Public |
| 21 May 2026 | PEG MGF | 10.0 A | 2mg | 1.7mg | -13.3% | 98.36% | gkyw2u | Lab D | Public |
| 20 May 2026 | Retatrutide | 10.0 A | 10mg | 10mg | 99.90% | RT10/2025-1010 | Lab E | Public | |
| 20 May 2026 | Anadrol Oil | 6.2 A | 300mg/ml | 293.0mg/ml | -2.3% | 96.71% | snd4n5 | Lab G | Public |
| 20 May 2026 | BPC157 5mg + TB500 5mg Blend | 5.6 B | 30mg | 31.0mg | +3.3% | 96.92% | h0w7s5 | Lab B | Public |
| 20 May 2026 | PTD-DBM | 8.3 A | 20mg | 24.8mg | +24.2% | 97.95% | v0px0u | Lab E | Public |
| 20 May 2026 | TB-500 FRAG | 4.9 C | 10mg | 10.4mg | +3.7% | 96.32% | z0heek | Lab C | Community |
| 20 May 2026 | Test Enanthate | 6.3 A | 300mg/ml | 321.8mg/ml | +7.3% | 96.07% | ibkivb | Lab F | Community |
| 17 May 2026 | Cartalax | 4.0 C | 20mg | 22.3mg | +11.4% | 98.37% | zububs | Lab G | Community |
| 29 Jan 2026 | Retatrutide | 7.3 A | 30mg | 30.6mg | +2.0% | 99.61% | (no batch ID) | Lab E | Public |
| 29 Jan 2026 | Semax | 8.0 A | 30mg | 33.4mg | +11.4% | 96.94% | l3dry4 | Lab A | Public |
| 26 Jan 2026 | Tirzepatide | 10.0 A | 60mg | 61.6mg | +2.7% | 99.90% | Triz60 | Lab G | Public |
| 26 Jan 2026 | GW-501516 (Cardarine) | 8.1 A | 25mg | 22.5mg | -10.1% | 96.48% | yjq7g0 | Lab G | Public |
| 26 Jan 2026 | Tirzepatide 30mg Pen Kit | 7.7 A | 30mg | 36.2mg | +20.7% | 99.28% | ba8sqj | Lab F | Community |
| 15 Jan 2026 | Retatrutide | 6.2 B | 5mg | 4.99mg | -0.2% | 99.09% | (no batch ID) | Lab E | Public |
| 9 Jan 2026 | Botulinum toxin | 7.9 A | 2mg | 1.7mg | -13.3% | 96.77% | 3sos69 | Lab B | Community |
| 9 Jan 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 9.4 A | 10mg | 10.8mg | +8.5% | 99.15% | 90rpam | Lab D | Community |
| 6 Jan 2026 | Lipo-C 120mg | 7.3 A | 300mg/ml | 285.4mg/ml | -4.9% | 95.18% | prdn45 | Lab D | Public |
| 12 Dec 2025 | BMK ethyl glycidate CAS 41232-97-7 | 9.2 A | 10g | 11.4g | +14.2% | 97.36% | hp5xuf | Lab A | Community |
| 12 Dec 2025 | Dermorphin | 6.4 A | 30mg | 28.4mg | -5.2% | 96.53% | a7rllg | Lab D | Community |
| 12 Dec 2025 | Ovagen | 6.3 A | 50mg | 58.6mg | +17.1% | 99.12% | 8rpnx7 | Lab B | Public |
| 5 Dec 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 10.0 A | 10g | 8.5g | -14.7% | 96.40% | xb5lti | Lab G | Community |
| 23 Nov 2025 | Dianabol | 5.7 B | 20mg | 21.7mg | +8.5% | 98.29% | fum1b1 | Lab G | Public |
| 23 Nov 2025 | L-Carnitine 500mg | 7.0 A | 250mg/ml | 239.2mg/ml | -4.3% | 99.49% | i8fhfz | Lab A | Public |
| 23 Nov 2025 | Prednisone | 8.5 A | 20mg | 21.8mg | +9.0% | 97.73% | rbpv1s | Lab G | Community |
| 18 Nov 2025 | Tirzepatide | 7.4 A | 30mg | 29.8mg | -0.7% | 99.65% | (no batch ID) | Lab E | Vendor |
| 5 Nov 2025 | Winstrol Oil (Stanozolol) | 5.7 B | 300mg/ml | 322.5mg/ml | +7.5% | 95.55% | yoplsc | Lab C | Community |
| 4 Nov 2025 | Proviron (Mesterolone) | 4.0 C | 20mg | 21.6mg | +7.9% | 95.87% | gjvms5 | Lab E | Community |
| 17 Oct 2025 | ACE-031 | 7.9 A | 10mg | 12.4mg | +23.5% | 97.09% | 6uznxe | Lab B | Public |
| 17 Oct 2025 | Supertest 450 | 7.5 A | 200mg/ml | 184.7mg/ml | -7.6% | 98.12% | d304b0 | Lab C | Public |
| 3 Oct 2025 | CJC-1295 With DAC | 7.2 A | 2mg | 2.2mg | +12.0% | 97.45% | gqinb5 | Lab E | Public |
| 3 Oct 2025 | MT-1 | 5.6 B | 5mg | 5.7mg | +13.2% | 98.51% | udj2h4 | Lab B | Community |
— END OF EVIDENCE LOG —